Bulletin from Studsvik AB's extraordinary general meeting on December 12, 2025

At its December 12, 2025 extraordinary general meeting Studsvik confirmed a six‑member board and elected Anders Bergdahl as a new director, to be paid pro rata at the 2025 AGM levels (SEK 236,250 plus possible committee fee SEK 50,000). The meeting authorized the board, until the next AGM and with the possibility to deviate from shareholders' preferential rights, to issue new shares and warrants/convertibles (payable in cash, set‑off, contribution in kind or combinations) corresponding to no more than 10% dilution on a fully‑utilized basis; the stated purposes are to enable company acquisitions, support expansion and for general corporate purposes with subscription prices set by market conditions. The authorization gives management near‑term flexibility for M&A and capital raising while creating a concrete, capped potential for equity dilution.

Analysis

Studsvik AB's extraordinary general meeting on December 12, 2025 confirmed a six-member Board and elected Anders Bergdahl as a new director; his pro rata remuneration was set at SEK 236,250 with an additional possible committee fee of SEK 50,000. The board composition change is procedural and compensated at the levels established at the 2025 Annual General Meeting, indicating no new governance-cost surprise.

The meeting authorized the Board, until the next AGM, to issue new shares and warrants and/or convertibles corresponding to no more than 10% dilution on a fully-utilized basis, permitting deviation from shareholders' preferential rights and allowing payment by cash, set-off, contribution in kind or combinations. The stated purposes are to provide flexibility for acquisitions, to facilitate expansion and for general corporate purposes, with subscription price to be set in line with market conditions.

This authorization materially increases near-term corporate flexibility for M&A and capital raising while capping dilution at 10%, but it also creates an explicit issuance pathway that could pressure the share base or increase volatility if executed; warrants/convertibles add derivative complexity and potential future dilution. Market-impact signals are neutral to modest (score ~0.12), so investors should watch for concrete issuance announcements, pricing details and any acquisition financing that uses equity or hybrids.

Key Decisions for Investors

• Monitor company announcements for any utilization of the 10% issuance authorization and the pricing of any share, warrant or convertible issues as these will determine dilution magnitude and immediate share-price impact
• Reassess position sizing if your exposure is sensitive to dilution or event-driven volatility; consider trimming or hedging ahead of confirmed equity-linked financings
• Treat potential issuance as supportive of acquisitive growth strategy but require transparent deal economics; demand disclosure on consideration (cash vs shares) and expected accretion before increasing exposure
• Watch for details on any contribution-in-kind transactions which can transfer asset risk to shareholders; pause material position increases until subscription price and deal terms are public